BLEXTEN
BLEXTEN
Approved
DIN Number
02454130
Drug Class
Human
Market Date
Dec 2, 2016
Company
HC
aralez pharmaceuticals canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02454130
AIG Number0158051001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
R06AX29 BILASTINE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification04:08.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
BILASTINEActive
Strength: 20 MG
Monograph: BILASTINE